Hypertension is a dangerous condition in which blood pres sure (BP) is persistently higher than normal. If left untreated, people with hypertension are at risk for heart attack, heart failure, stroke, and kidney failure.
However, systolic pressure varies throughout the arterial tree, such that aortic (central) systolic pressure is actually lower than corresponding brachial values, although this difference is highly variable between individuals. From a physiologic viewpoint, central aortic blood pressure (CABP), at least in elderly, is likely to be more relevant than the peripheral BP. CABP has a stronger correlation with the degree of left ventricular hypotrophy, heart failure, myocardial infarction (MI), and stroke than cuff pressure recording. 1 Owing to vascular aging, arterial distensibility decreases with age, and this leads to increased systolic pressure in the aorta and increased pulse pressure consistently. Sev eral limitations exist with peripheral blood pressure. First, central aortic pressure is a better predictor of cardiovas cular outcome than peripheral pressure. Second, peripher ally obtained BP does not accurately reflect central pressure because of pressure amplification. Last, antihypertensive medications have differing effects on central pressures des pite similar reductions in brachial BP. Therefore, it is better to consider the CABP for therapeutic interventions. Even though the most accurate way of recording CABP is direct pressure recording from the catheter in the aorta during car diac catheterization, the most practical and easiest way is to derive CABP by noninvasive methods such as applanation tonometry. 2 Certain drugs that are generally used, such as β-blockers, may not lower the central BP. The Conduit Artery Function Evaluation (CAFE) study, a substudy of the Anglo Scandina vian Cardiac Outcomes Trial (ASCOT), examined the impact of two different BPlowering regimens (atenolol ± thia zidebased vs. amlodipine ± perindoprilbased therapy) on derived central aortic pressures and hemodynamics. 3 Meta analysis showed that atenolol is effective at decreasing the cuff BP but not CABP. Drugs of choice would be calcium channel blocker and angiotensin II receptor blocker (ARB) in elderly people along with diuretics such as chlorthalidone. They have greater therapeutic safety in their property of low ering central BP in elderly people. 4 The PEAR (Pharmacogenomic Evaluation of Antihyper tensive Responses) study was done to identify demographic and clinical factors associated with central pressures in patients with uncomplicated hypertension. Significant pre dictors of central systolic blood pressure (SBP) included height, smoking status, heart rate (HR), and peripheral SBP, whereas central diastolic blood pressure (DBP) was explained by peripheral DBP and HR. 5 Various studies have shown that up to 80 years of age, SBP of 140 has to be the cutoff point. In very elderly people older than 80 years, probably 150 and other levels could be individualized. 6 In the present issue of the journal, Hemamalini et al pre sented the data of the CABP from the south Indian popula tion, as there are limited studies from this population. They found that CABP is statistically significantly lower than the man ually recorded peripheral SBP irrespective of sex, hyper tension, diabetes status, and use of β-blockers. A small but significant difference was observed between machine derived peripheral DBP and central aortic DBP.
